Literature DB >> 23061340

FDA approves liposomal vincristine (Marqibo) for rare leukemia.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061340

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  4 in total

Review 1.  Nanomedicines for renal disease: current status and future applications.

Authors:  Nazila Kamaly; John C He; Dennis A Ausiello; Omid C Farokhzad
Journal:  Nat Rev Nephrol       Date:  2016-10-31       Impact factor: 28.314

2.  Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia.

Authors:  Meir Wetzler; Debora A Thomas; Eunice S Wang; Robert Shepard; Laurie A Ford; Thompson L Heffner; Samir Parekh; Michael Andreeff; Susan O'Brien; Hagop M Kantarjian
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-06-10

Review 3.  Application of lipid nanovesicle drug delivery system in cancer immunotherapy.

Authors:  Yinan Ding; Luhong Wang; Han Li; Fengqin Miao; Zhiyuan Zhang; Chunmei Hu; Weiping Yu; Qiusha Tang; Guoliang Shao
Journal:  J Nanobiotechnology       Date:  2022-05-06       Impact factor: 9.429

Review 4.  Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression.

Authors:  Bonglee Kim; Ji-Eon Park; Eunji Im; Yongmin Cho; Jinjoo Lee; Hyo-Jung Lee; Deok-Yong Sim; Woon-Yi Park; Bum-Sang Shim; Sung-Hoon Kim
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.